Safe Penicillin Allergy Delabeling in Primary Care: A Systematic Review and Meta-Analysis
The Journal of Allergy and Clinical Immunology: In Practice · 2024-09 · 12 (9) · 2415-2426.e1
DOI: 10.1016/j.jaip.2024.06.017 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2024-09. Verfasst von Florian Stul und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium. Electronic address: Florian.…. Hauptthemen laut MEDLINE: Drug Hypersensitivity, Penicillins, Primary Health Care. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 71 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Ten percent of the population is labeled as allergic to penicillin(s), when in fact 90% of these labels are inappropriate. Recent studies have shown that inpatient delabeling by a direct drug challenge (dDC) is safe in low-risk patients. However, there is a need for outpatient and nonallergist delabeling. OBJECTIVE: To assess the safety of delabeling low-risk adults by means of dDC in primary care. METHODS: We searched the MEDLINE, Embase, and Cochrane Library databases from inception to March 15, 2022 (updated June 5, 2023) for studies performing dDC in adults in primary care or other outpatient settings. Two researchers independently screened studies for eligibility. The data extraction and critical appraisal were performed by 1 reviewer, and we pooled the results in a meta-analysis. RESULTS: Of 2138 results, 12 studies (1070 participants) were eligible for inclusion. Three studies evaluated delabeling in primary care and 9 studies in an outpatient hospital setting. There were no critical adverse events during dDC. No reaction occurred in 97.13% of the 1070 patients, who previously labeled as penicillin-allergic, and were safely delabeled. Ten patients (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium. Electronic address: Florian.Stul@Ugent.be.
- Department of Public Health and Primary Care, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
- Department of Immunology, Allergology and Rheumatology, University of Antwerp, Antwerp University Hospital, Antwerp, Belgium.
Zitieren
APA
Stul, F., Heytens, S., Ebo, D. G., Sabato, V., & Piessens, V. (2024). Safe Penicillin Allergy Delabeling in Primary Care: A Systematic Review and Meta-Analysis. The Journal of Allergy and Clinical Immunology: In Practice, 12(9), 2415-2426.e1. https://doi.org/10.1016/j.jaip.2024.06.017
Vancouver
Stul F, Heytens S, Ebo DG, Sabato V, Piessens V. Safe Penicillin Allergy Delabeling in Primary Care: A Systematic Review and Meta-Analysis. The Journal of Allergy and Clinical Immunology: In Practice. 2024;12(9):2415-2426.e1. doi:10.1016/j.jaip.2024.06.017
BibTeX
@article{Stul2024,
author = {Stul, Florian and Heytens, Stefan and Ebo, Didier Gaston and Sabato, Vito and Piessens, Veerle},
title = {Safe Penicillin Allergy Delabeling in Primary Care: A Systematic Review and Meta-Analysis},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
year = {2024},
volume = {12},
number = {9},
pages = {2415--2426.e1},
doi = {10.1016/j.jaip.2024.06.017}
}
EUVIMED